Literature DB >> 25816840

Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples.

Annette M Staiger1,2, M Michaela Ott3, Stefani Parmentier4, Andreas Rosenwald5, German Ott6, Heike Horn1,2, Ernst-Ulrich Griese1,2.   

Abstract

Entities:  

Keywords:  MYD88 L265P; allele-specific polymerase chain reaction; diffuse large B-cell lymphomas; lymphoplasmacytic lymphoma; molecular diagnostics

Mesh：

Substances：

Year:  2015        PMID： 25816840     DOI： 10.1111/bjh.13369

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hyun-Young Kim; Chang-Hun Park; Hee-Jin Kim; Jong-Won Kim; Seok Jin Kim; Won Seog Kim; Sun-Hee Kim
Journal:  Blood Res       Date:  2016-09-23

2.  High frequency and prognostic value of MYD88 L265P mutation in diffuse large B-cell lymphoma with R-CHOP treatment.

Authors:  Sisi Yu; Huaichao Luo; Meiling Pan; Luis Angel Palomino; Xiaoyu Song; Ping Wu; Jian-Ming Huang; Zhihui Zhang
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

3.  Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.

Authors:  Ju-Han Lee; Hoiseon Jeong; Jung-Woo Choi; HwaEun Oh; Young-Sik Kim
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

4.  Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.

Authors:  Tina Bagratuni; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Nefeli Mavrianou-Koutsoukou; Christine Liacos; Dimitrios Patseas; Nikolaos Kanellias; Magdalini Migkou; Dimitrios C Ziogas; Evangelos Eleutherakis-Papaiakovou; Maria Roussou; Despina Fotiou; Evangelos Terpos; Efstathios Kastritis; Meletios A Dimopoulos
Journal:  Leukemia       Date:  2018-07-19       Impact factor: 11.528

Review 5.  MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.

Authors:  Ruben A L de Groen; Anne M R Schrader; Marie José Kersten; Steven T Pals; Joost S P Vermaat
Journal:  Haematologica       Date:  2019-11-07       Impact factor: 9.941

Review 6.  Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.

Authors:  Wei Jian Tan; Mona Meng Wang; Paola Ricciardi-Castagnoli; Anita Sook Yee Chan; Tong Seng Lim
Journal:  Front Mol Biosci       Date:  2021-01-11

7.  MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene.

Authors:  Shu-Chao Qin; Yi Xia; Yi Miao; Hua-Yuan Zhu; Jia-Zhu Wu; Lei Fan; Jian-Yong Li; Wei Xu; Chun Qiao
Journal:  Blood Cancer J       Date:  2017-12-15       Impact factor: 11.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.